Kestra Medical Technologies, Ltd. Common Stock (KMTS) financials · rev $95.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Kestra Medical Technologies, Ltd. Common Stock (KMTS) rev $95.1M.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $95.1M | $59.8M |
| Cost of Revenue | $46.3M | $35.6M |
| Gross Profit | $48.9M | $24.2M |
| Operating Income | -$134.7M | -$106.4M |
| Net Income | -$131.6M | -$113.8M |
| EPS (Diluted) | -$2.43 | -$5.13 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $358.5M | $295.7M |
| Current Assets | $222.4M | $255.3M |
| Cash & Equivalents | $99.7M | $237.6M |
| PP&E | $59.1M | $34.8M |
| Total Liabilities | $98.8M | $90.3M |
| Current Liabilities | $50.4M | $38.0M |
| Long-term Debt | $42.6M | $41.1M |
| Total Debt | $42.6M† | $41.1M† |
| Shareholders' Equity | $259.7M | $205.4M |
| Retained Earnings | -$651.9M | -$520.2M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$81.7M | -$77.6M |
| CapEx | $34.9M | $22.9M |
| Investing Cash Flow | -$203.3M | -$23.3M |
| Financing Cash Flow | $147.1M | $330.3M |
| Net Change in Cash | -$137.9M | $229.3M |
| Free Cash Flow | -$116.6M | -$100.5M |
FAQ
What is KMTS P/E and revenue?
Kestra Medical Technologies, Ltd. Common Stock (KMTS) rev $95.1M.
What is KMTS revenue?
Kestra Medical Technologies, Ltd. Common Stock last cached revenue is $95.1M (FY2026).
Is KMTS profitable?
Kestra Medical Technologies, Ltd. Common Stock last cached net income is -$131.6M (FY2026).
What are KMTS total assets?
Kestra Medical Technologies, Ltd. Common Stock last cached total assets are $358.5M (FY2026).
What is KMTS free cash flow?
Kestra Medical Technologies, Ltd. Common Stock last cached free cash flow is -$116.6M (FY2026).
Not investment advice. Cached statements, not a live tape.